Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of tazarotene + betamethasone dipropionate cream for psoriasis vulgaris
ChiCTR1900024450Phase 3Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tazarotene and betamethasone dipropionate in plaque psoriasis and psoriasis (3 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Decline rate of PASI. Started Mar 2010; status: completed.
02
Drugs
tazarotenebetamethasone dipropionate
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on ChiCTR1900024450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024450.